Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays

Journal of Lipid Research

Volumn 52, Issue 12, 2011, Pages 2323-2331

  Dernick, Gregor ^a   Obermüller, Stefan ^a   Mangold, Cyrill ^a   Magg, Christine ^a,b   Matile, Hugues ^a   Gutmann, Oliver ^a   Von Der Mark, Elisabeth ^a   Handschin, Corinne ^a   Maugeais, Cyrille ^a   Niesor, Eric J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

Fast protein liquid chromatography; HDL proteomics; Protein lipid interaction; Protein protein interaction; Reverse phase arrays; Size exclusion chromatography

Indexed keywords

ANACETRAPIB; APOLIPOPROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; DALCETRAPIB; LIPOPROTEIN; PRE BETA HIGH DENSITY LIPOPROTEIN; TORCETRAPIB;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GEL PERMEATION CHROMATOGRAPHY; HUMAN; MOLECULAR SIZE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN MICROARRAY; SENSITIVITY ANALYSIS;

ANTIBODY SPECIFICITY; ARTIFACTS; BLOOD CHEMICAL ANALYSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, GEL; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; LIPOPROTEINS; PROTEIN ARRAY ANALYSIS; QUINOLINES; REPRODUCIBILITY OF RESULTS;

EID: 80052325057     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D016824     Document Type: Article

References (30)

1. Wiesner, P., K. Leidl, A. Boettcher, G. Schmitz, and G. Liebisch. 2009. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J. Lipid Res. 50: 574-585.
2. Davidsson, P., J. Hulthe, B. Fagerberg, and G. Camejo. 2010. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 30: 156-163.
3. Heinecke, J. W. 2009. The HDL proteome: a marker - and perhaps mediator - of coronary artery disease. J. Lipid Res. 50 (Suppl.) : 167-171.
4. Hoofnagle, A. N., and J. W. Heinecke. 2009. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J. Lipid Res. 50: 1967-1975.
5. Ståhlman, M., P. Davidsson, I. Kanmert, B. Rosengren, J. Boren, B. Fagerberg, and G. Camejo. 2008. Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J. Lipid Res. 49: 481-490. (Pubitemid 351213633)
6. Gordon, S. M., J. Deng, L. J. Lu, and W. S. Davidson. 2010. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Res. 9: 5239-5249.
7. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261. (Pubitemid 13030685)
8. Heller, M., D. Stalder, E. Schlappritzi, G. Hayn, U. Matter, and A. Haeberli. 2005. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins. Proteomics. 5: 2619-2630. (Pubitemid 40966489)
9. Rezaee, F., B. Casetta, J. H. Levels, D. Speijer, and J. C. Meijers. 2006. Proteomic analysis of high-density lipoprotein. Proteomics. 6: 721-730. (Pubitemid 43208050)
10. Cohn, J. S., M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, J. Genest, Jr., and J. Davignon. 1996. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16: 149-159. (Pubitemid 26026945)
11. Murdoch, S. J., G. Wolfbauer, H. Kennedy, S. M. Marcovina, M. C. Carr, and J. J. Albers. 2002. Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. J. Lipid Res. 43: 281-289. (Pubitemid 34184015)
12. Tellis, C. C., and A. D. Tselepis. 2009. The role of lipoprotein- associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim. Biophys. Acta. 1791: 327-338.
13. Anderson, N. L., and N. G. Anderson. 2002. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 1: 845-867.
14. Colvin, P. L., and J. S. Parks. 1999. Metabolism of high density lipoprotein subfractions. Curr. Opin. Lipidol. 10: 309-314. (Pubitemid 29419687)
15. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cellderived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29. (Pubitemid 18036281)
16. Asztalos, B. F., L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer. 2004. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 24: 2181-2187. (Pubitemid 39482449)
17. Hennes, U., W. Gross, and A. Edelmann. 1992. Changes in lipoprotein patterns in hamsters under different metabolic states analyzed following separation by micropreparative chromatography on SMART System from multiple micro plasma samplings. Science Tools. 36: 10-12.
18. Innis-Whitehouse, W., X. Li, W. V. Brown, and N. A. Le. 1998. An efficient chromatographic system for lipoprotein fractionation using whole plasma. J. Lipid Res. 39: 679-690. (Pubitemid 28158409)
19. Paweletz, C. P., L. Charboneau, V. E. Bichsel, N. L. Simone, T. Chen, J. W. Gillespie, M. R. Emmert-Buck, M. J. Roth, I. E. Petricoin, and L. A. Liotta. 2001. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 20: 1981-1989. (Pubitemid 32458030)
20. Gray, M. C., A. L. Plant, J. M. Nicholson, and W. E. May. 1995. Microenzymatic fluorescence assay for serum cholesterol. Anal. Biochem. 224: 286-292.
21. Weinberg, R. B., V. R. Cook, J. B. Jones, P. Kussie, and A. R. Tall. 1994. Interfacial properties of recombinant human cholesterol ester transfer protein. J. Biol. Chem. 269: 29588-29591. (Pubitemid 24365111)
22. Ohnishi, T., S. Yokoyama, and A. Yamamoto. 1990. Rapid purifi cation of human plasma lipid transfer proteins. J. Lipid Res. 31: 397-406. (Pubitemid 20107980)
23. nd edition. American Association for Clinical Chemistry, Washington, DC.
24. Chiba, H., M. Eto, S. Fujisawa, K. Akizawa, S. Intoh, O. Miyata, K. Noda, K. Matsuno, and K. Kobayashi. 1993. Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency. Biochem. Med. Metab. Biol. 49: 79-89. (Pubitemid 23197769)
25. Collins, L. A., S. P. Mirza, A. H. Kissebah, and M. Olivier. 2010. Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry. Physiol. Genomics. 40: 208-215.
26. Clark, R. W., R. B. Ruggeri, D. Cunningham, and M. J. Bamberger. 2006. Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action. J. Lipid Res. 47: 537-552. (Pubitemid 43345595)
27. Niesor, E. J., C. Magg, N. Ogawa, H. Okamoto, E. von der Mark, H. Matile, G. Schmid, R. G. Clerc, E. Chaput, D. Blum-Kaelin, et al. 2010. Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport. J. Lipid Res. 51: 3443-3454.
28. Kunitake, S. T., C. M. Mendel, and L. K. Hennessy. 1992. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J. Lipid Res. 33: 1807-1816. (Pubitemid 23006657)
29. Garber, D. W., K. R. Kulkarni, and G. M. Anantharamaiah. 2000. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J. Lipid Res. 41: 1020-1026. (Pubitemid 30434334)
30. Fattinger, C., and G. Dernick. 2006. High-density plates, microarrays, microfluidics. In Exploiting Chemical Diversity for Drug Discovery. P. A. Bartlet and M. Entzeroth, editors. The Royal Society of Chemistry, Cambridge. 203-232.